In patients with OS, immunosuppressive cells, supportive cells within the TME, and tumor cells can release programmed death ligand 1 (PD-L1) via exosomes, which collectively contribute to systemic immunosuppression (87). The gene discussed is CD274; the disease is neoplasm.